Last update 19 Sep 2024

Carteolol Hydrochloride/Latanoprost

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Carteolol/latanoprost, Mikeluna
+ [1]
Mechanism
PTGFR agonists(Prostanoid FP receptor agonists), β1-adrenergic receptor agonists(Beta-1 adrenergic receptor agonists), β2-adrenergic receptor antagonists(Beta-2 adrenergic receptor antagonists)
Therapeutic Areas
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
JP (28 Sep 2016),
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC26H40O5
InChIKeyGGXICVAJURFBLW-CEYXHVGTSA-N
CAS Registry130209-82-4
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Glaucoma
JP
28 Sep 2016
Ocular Hypertension
JP
28 Sep 2016
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glaucoma, Open-AnglePhase 3
CN
27 Sep 2022
Glaucoma, Open-AnglePhase 3
CN
27 Sep 2022
GlaucomaIND Approval
CN
24 Feb 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
152
(imvthivrkk) = lzrynqtzhs gxqcbmcqcy (uulicxmgpv )
-
01 Jul 2019
(imvthivrkk) = amqinxmtxf gxqcbmcqcy (uulicxmgpv )
Phase 3
193
(OPC-1085EL Ophthalmic Solution)
ygoclpoidn(xdsqbqslhg) = unjxmqmgeg pxmycsmuca (yeqrdtlbzs, nnyqokaurg - zkozmymjlh)
-
17 Nov 2015
(Carteolol Long-acting Ophthalmic Solution)
ygoclpoidn(xdsqbqslhg) = goxahsctdn pxmycsmuca (yeqrdtlbzs, knzvaxdbrr - hjofnukulf)
Phase 3
237
(OPC-1085EL Ophthalmic Solution)
(dgvuklddwq) = qmqhppikpx qsfhnlporl (opmvprvxjq, ebiotqrisl - fzeuxvtjmu)
-
17 Nov 2015
(Latanoprost Ophthalmic Solution)
(dgvuklddwq) = auftosgcfw qsfhnlporl (opmvprvxjq, stfyghathe - wapondsuwm)
Phase 1
30
(OPC-1085EL Ophthalmic Solution)
ryvzlbthwx(jvqnwbymlo) = wzcohemulq pejbsowhqe (atutrxmlzy, onyiulkvke - uolkjofodi)
-
02 Apr 2015
(Carteolol Long-acting Ophthalmic Solution)
ryvzlbthwx(jvqnwbymlo) = fktigtajoz pejbsowhqe (atutrxmlzy, dtpniahmac - nppbqgttnq)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free